Q301--Renal Transplant and Routine Biopsy (VA-25-00076660)

The Department of Veterans Affairs issued a Sources Sought Notice (Solicitation Number 36C24225Q0732) to gather information on the availability of Service-Disabled Veteran Owned Small Businesses or Veteran Owned Small Businesses capable of delivering Renal Transplant and Routine Biopsy services for the James J. Peters VA Medical Center in Bronx, NY. The services include processing Renal Tissue Biopsies, and providing analysis by a Renal Pathologist, with requirements for both routine and transplant patients. The anticipated award date is September 1, 2025. Contractors must ensure prompt analysis of received tissue samples, with specific timelines for preliminary reporting completed within the same day or the following day for after-hours submissions. Interested firms must submit their capabilities by June 24, 2025, including company information and past performance, emphasizing their ability to meet the outlined specifications. This request serves as market research and is not a binding contract, aiming to assess contractor capabilities in a competitive procurement context while defining the necessary qualifications and response requirements for potential vendors in the medical services sector.

The Department of Veterans Affairs is soliciting information on available services for Renal Transplant and Routine Biopsy processing through RFQ number 36C24225Q0732, specifically targeting both small and large businesses. This notice, which is not a solicitation for bids but rather a request for market research, seeks to assess the capabilities of providers for renal biopsy services required at the James J. Peters VA Medical Center in Bronx, NY. The estimated requirement includes around 50 renal biopsies annually, necessitating timely processing and detailed analyses for patient management. The anticipated contract award is set for September 1, 2025, under the NAICS code 621511 (Medical Laboratories). Interested firms must submit their capabilities and relevant past performance information by July 10, 2025. The submission should include company details, small business classification, and evidence of experience in providing similar services. This inquiry underscores the VA's focus on enhancing healthcare for veterans through robust partnerships with qualified service providers.

The James J. Peters VA Medical Center requires a contractor to provide Renal Transplant Services and processing for Routine Renal Tissue Biopsies. Services include various examinations and analyses, such as Light Microscopy, Immunohistochemistry, and Electron Microscopy, for an estimated 50 biopsies annual. The contractor must deliver preliminary reports promptly, with strict timelines for processing dependent on when biopsies are received. The contract spans a base year plus four options, with fixed pricing for each year totaling approximately $37,754.50 annually. Contractors must comply with federal laws regarding information security and data protection. They are required to complete VA training and adhere to regulations pertaining to accessing VA information systems. Unauthorized use or disclosure of VA information may lead to contract termination. The document emphasizes the importance of safeguarding sensitive data, ensuring compliance with applicable regulations, and maintaining a focus on patient-centered services during the contract period.

The James J. Peters VA Medical Center seeks to procure Renal Transplant Services and perform Routine Renal Tissue Biopsies, including specialized analyses such as Immunohistochemistry (IHC) and Electron Microscopy (EM). These services are essential for managing both routine and transplant patients, with pathology evaluations conducted on renal tissue biopsies before and after transplantation. Interested parties are required to submit an Expression of Interest (EOI) that includes a comprehensive review of the attached Statement of Work (SOW), a completed Special Notice for Sole Source Intent, and a Technical Capability Statement demonstrating their qualifications. Additional documentation includes a specific notice concerning procurement strategy and sources viability for the renal transplant and biopsy processing tasks. This solicitation, referenced under the solicitation number 36C24225Q0732, is being managed by the Veterans Affairs Network Contracting Office, with a response deadline of July 29, 2025. The work aims to enhance the delivery of healthcare services to veterans requiring specialized renal services, reflecting the VA's commitment to improving patient care in this area.

This Special Notice issued by the VISN 2 Contracting Office in Albany, NY, announces an intent to determine the procurement strategy and viability of sources for a new service related to the James J. Peters VA Medical Center in Bronx, NY. The notice outlines that it is not a request for proposals and will be treated as market research. The Government is seeking capability statements from interested contractors, especially those eligible under specific socio-economic categories, by encouraging them to submit detailed information to assess their capacity to fulfill the requirements for medical laboratory services (NAICS Code 621511) effective September 1, 2025. Contractors must provide documentation, past performance examples, and proof of socio-economic status to be considered. The notice emphasizes limitations on subcontracting, requiring firms to maintain a certain percentage of work to be performed in-house and includes obligatory compliance certification. This process aims to ensure that the Government identifies suitable small businesses and develops an effective sourcing strategy aligned with federal contracting regulations and socio-economic goals. The response deadline is not explicitly mentioned but entails careful compliance with the outlined requirements for consideration.

The Department of Veterans Affairs has announced its intention to award a sole source contract to Columbia University for renal transplant services. After conducting market research, Columbia University was determined to be the only vendor capable of fulfilling the requirements, which include offering pathology analysis and diagnostic services for renal biopsies essential for managing transplant recipient patients. The performance period for the contract is set from September 1, 2025, to August 31, 2026. All expressions of interest (EOI) from potential competitors must be submitted by August 15, 2025. While responses will be considered to evaluate whether a competitive procurement process is warranted, the document clearly states that no solicitation document exists, and inquiries will not be accepted. Interested parties are required to email their EOI along with a technical capability statement and any required documentation. This notice reflects the government’s approach to streamline services by identifying a vendor with the necessary specialized expertise.